MedPath

Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia

Not Applicable
Completed
Conditions
Alzheimer's Disease
Interventions
Device: Active lighting intervention
Device: Control lighting intervention
Registration Number
NCT05519137
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Brief Summary

To test the effect of a tailored lighting intervention controlled by the Readings At Desk (RAD) controller on sleep and mood in Alzheimer's disease participants.

Detailed Description

Each participant will be enrolled for 22 weeks. Participants will be randomly assigned to receive either the active or control lighting condition. Each lighting condition will be 8 weeks in length. After a 4 week washout, each participant will crossover to the opposite condition. Assessments will be performed before and at the end of each lighting intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Control lighting condition then Active light interventionActive lighting interventionEach lighting condition will be 8 weeks in length. After a 4 week washout, each participant will crossover to the opposite condition.
Control lighting condition then Active light interventionControl lighting interventionEach lighting condition will be 8 weeks in length. After a 4 week washout, each participant will crossover to the opposite condition.
Active lighting intervention then Control lighting conditionActive lighting interventionEach lighting condition will be 8 weeks in length. After a 4 week washout, each participant will crossover to the opposite condition.
Active lighting intervention then Control lighting conditionControl lighting interventionEach lighting condition will be 8 weeks in length. After a 4 week washout, each participant will crossover to the opposite condition.
Primary Outcome Measures
NameTimeMethod
Sleep disturbance using the Pittsburgh Sleep Quality Indexup to 22 weeks

The Pittsburgh Sleep Quality Index (PSQI) is composed of 19 items that generate 7 component scores. The sum of the 7 component scores yields a single global score with a range of 0 to 21. A global score \>5 is considered to indicate sleep disturbances. A lower global score indicates improvement in sleep disturbance.

Secondary Outcome Measures
NameTimeMethod
Depression screening utilizing the Cornell Scale for Depression in Dementia (CSDD)up to 22 weeks

The CSDD is a a 19-item tool designed to rate symptoms of depression in patients with dementia. This tool evaluates the presence and extent of mood-related signs. Scores range from 0 to 38 with a higher score indicating higher depressive symptoms.

Sleep efficiency measured by actigraphyup to 22 weeks

Sleep efficiency is calculated from the wrist worn actigraph by the software program as the percentage of the time in bed spent sleeping. The ratio of total sleep time (TST) to total time in bed (TIB) multiplied by 100 to yield a percentage.

Trial Locations

Locations (1)

Light and Health Research Center

🇺🇸

Menands, New York, United States

© Copyright 2025. All Rights Reserved by MedPath